期刊文献+

高危型HPV在宫颈癌发生中的作用 被引量:5

Effect of High-risk Human Papillomavirus on Cervical Carcinogenesis
下载PDF
导出
摘要 本文利用PCR技术检测了44例宫颈癌患者和15例慢性宫颈炎患者病变组织中高危型HPV(16,18,31,33)的感染率,发现44例宫颈癌患者高危型HPV的阳性率高达91%(40/44),其中HPV16型感染率54.55%(24/44),HPV18型感染率18.2%(8/44),HPV31型感染率13.6%(6/44),HPV33型感染率4.55%(2/44);15例慢性宫颈炎患者有2例感染HPV16型。结果提示HPV16型是宫颈癌发生最常见的基因型,其次为HPV18型和HPV31型,故对育龄妇女定期进行高危型HPV感染的普查,在早期预防宫颈癌的发生具有十分重要的意义;联合采用分子生物学和宫颈脱落细胞学技术进行即定期普查,既能提高阳性率,又能对感染高危型HPV的慢性宫颈炎患者进行早期的有效预防。 The infection rates of high- risk human papillomavirus (HPV, typel6, 18, 31, 33) were detected by polymerase chain reaction (PCR) in 44 cervical carcinomas and 15 chronic cervicitis. The results showed that the positive rates of HPV were 91% (40/44), among which HPV type 16 consisted 54.55% (24/44), HPV 18 18.2% (8/44), HPV 31 13.6% (6/ 44) and HPV 33 4.55% (2/44) in 44 cervical carcinomas; while HPV 16 were positive in only 2 of 15 women with chronic cervicitis. The data suggested that the most common prevailing HPV type was HPV 16, and the next HPV 18 and 31. It is necessary for prevention of bervical carcinogenesis early by periodic extensive screening of high- risk HPV for women during childbearing age. Combination application of molecular biological and cervical exfoliocytological techniques is useful for periedical extensive screening of cervix disease, which is not only elevated the positive yields, but also permitted early prevention of cervical carcinogenesis for women infected with high- risk HPV.
出处 《实用预防医学》 CAS 2005年第5期1023-1024,共2页 Practical Preventive Medicine
关键词 宫颈癌 人类乳头状瘤病毒 多聚酶链式反应 Cervical carcinoma High- risk human papillomaviruses Polymerase chain reaction
  • 相关文献

参考文献4

  • 1Lin H, Moh JS, Ou YC, et al. A simple method for the detection and genotyping of high-risk human papillomavirus using seminested polymerase chain reaction and reverse hybridization [ J ]. Gynecol Oncol,2005,96(1) :84-91.
  • 2李淑敏,章文华,吴令英,赵芳辉,黄曼妮,李楠,陈凤.人乳头状瘤病毒负荷量与子宫颈癌及其癌前病变关系的初步研究[J].中华妇产科杂志,2004,39(6):400-402. 被引量:76
  • 3Vince A, Kutela N, Iscic-Bea J, et al. Clinical utility of molecular detection of human papillomavirus in cervical samples by hybrid capture technology[J]. J Clin Virol, 2002,25, Suppl 3: S109-12.
  • 4Wright Jr TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening[J]. Obstet Gynecol, 2004,103: 304-9.

二级参考文献8

  • 1Wooan CB,Collins S,Winter H,et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.Lancet, 2001, 357(9271):1831-1836.
  • 2ter Harmsel B,edts F,Kuijpers J,et al. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. Obstet Gynecol, 1999,93:46-50.
  • 3Nicolas FS, Andrea T, Eliane DF, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer, 2003, 103: 519-524.
  • 4Clavel C, Masure M, Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer, 1999,80:1306-1311.
  • 5Recio FD, Sahai Srivastava BI, Wong C, et al. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap ears.Eur J Gynaecol Oncol,1998,19:203-208.
  • 6Howard M, Sellors J, Kaczorowsli J. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia.Obstet Gynecol,2002, 100(5 Pt 1):972-980.
  • 7Vince A, Kutela N, Iscic BJ, et al. Clinical utility of molecular detection of human papillomavirus in cervical samples by hybrid capture technology. J Clin Virology, 2002, 25: 109-112.
  • 8Poljak M, Marin IJ, Seme K, et al. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol, 2002,25 Suppl 3:S89-97.

共引文献75

同被引文献65

引证文献5

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部